We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRISIL:NSECRISIL Limited Analysis

Data as of 2026-03-15 - not real-time

₹4,155.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

CRISIL shares are trading at ₹4,155, barely above the identified support of ₹4,144 and well below the 20‑day SMA of ₹4,408, indicating a fragile price floor. Technicals are decidedly bearish – the MACD histogram is negative, RSI sits at 34.5, and volume trends are decreasing, all pointing to continued downside pressure. Valuation metrics are stretched, with a trailing P/E of 39.6 versus an industry average of 16.4 and a DCF‑derived fair value of only ₹1,159, suggesting the market is pricing in excessive optimism. Despite the price weakness, fundamentals remain robust: revenue grew 18.5% YoY, operating margin sits at 28%, and cash on hand exceeds ₹10 bn while debt is modest at ₹3 bn. The company delivers a dividend yield of 2.69% with a payout ratio around 56%, supporting a sustainable income stream for investors. Recent credit‑rating upgrades for a client underscore CRISIL’s strong market reputation, but the current “Greed” sentiment (Fear‑Greed Index 72.9) combined with high 30‑day volatility (≈30%) adds caution to the outlook.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and RSI below 40
  • Price trading just above support with decreasing volume
  • Significant valuation gap between market price and DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong earnings growth and cash generation
  • Sustainable dividend payout
  • Overvaluation may persist but fundamentals remain solid

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent revenue and profit margin expansion
  • High ROE (~27%) and low beta indicating defensive characteristics
  • Growing demand for credit ratings and analytics services globally

Key Metrics & Analysis

Financial Health

Revenue Growth18.50%
Profit Margin20.99%
P/E Ratio39.6
ROE27.37%
ROA13.95%
Debt/Equity9.79
P/B Ratio10.0
Op. Cash Flow₹7.6B
Free Cash Flow₹2.7B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI34.5
Support₹4,144.00
Resistance₹4,676.60
MA 20₹4,407.51
MA 50₹4,559.12
MA 200₹4,932.49
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value₹1,158.96
Target Price₹4,904.00
Upside/Downside18.02%
GradeOvervalued
TypeGrowth
Dividend Yield2.69%

Risk Assessment

Beta0.42
Volatility30.70%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.